Singapore markets open in 1 hour 32 minutes
Straits Times Index
3,296.89 +4.20 (+0.13%) S&P 500
5,064.20 +45.81 (+0.91%) Dow
38,225.66 +322.37 (+0.85%) Nasdaq
15,840.96 +235.48 (+1.51%) Bitcoin USD
59,264.06 +1,374.05 (+2.37%) CMC Crypto 200
1,276.35 +5.61 (+0.44%)
Spero Therapeutics, Inc. (SPRO)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 83.00M |
| Enterprise value | 12.21M |
| Trailing P/E | 3.58 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.84 |
| Price/book (mrq) | 0.78 |
| Enterprise value/revenue | 0.13 |
| Enterprise value/EBITDA | 0.47 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.57 |
| 52-week change 3 | -17.82% |
| S&P500 52-week change 3 | 23.57% |
| 52-week high 3 | 1.9950 |
| 52-week low 3 | 0.9900 |
| 50-day moving average 3 | 1.6275 |
| 200-day moving average 3 | 1.3957 |
Share statistics
| Avg vol (3-month) 3 | 319.36k |
| Avg vol (10-day) 3 | 203.67k |
| Shares outstanding 5 | 53.89M |
| Implied shares outstanding 6 | 54.64M |
| Float 8 | 39.8M |
| % held by insiders 1 | 20.16% |
| % held by institutions 1 | 26.19% |
| Shares short (15 Apr 2024) 4 | 513.16k |
| Short ratio (15 Apr 2024) 4 | 1.62 |
| Short % of float (15 Apr 2024) 4 | 1.16% |
| Short % of shares outstanding (15 Apr 2024) 4 | 0.95% |
| Shares short (prior month 15 Mar 2024) 4 | 613.85k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 21.98% |
| Operating margin (ttm) | 68.73% |
Management effectiveness
| Return on assets (ttm) | 10.90% |
| Return on equity (ttm) | 24.95% |
Income statement
| Revenue (ttm) | 103.78M |
| Revenue per share (ttm) | 1.97 |
| Quarterly revenue growth (yoy) | 55.00% |
| Gross profit (ttm) | N/A |
| EBITDA | 27.15M |
| Net income avi to common (ttm) | 22.81M |
| Diluted EPS (ttm) | 0.4300 |
| Quarterly earnings growth (yoy) | 91.20% |
Balance sheet
| Total cash (mrq) | 76.33M |
| Total cash per share (mrq) | 1.42 |
| Total debt (mrq) | 5.54M |
| Total debt/equity (mrq) | 5.19% |
| Current ratio (mrq) | 3.53 |
| Book value per share (mrq) | 2.02 |
Cash flow statement
| Operating cash flow (ttm) | -32.99M |
| Levered free cash flow (ttm) | -9.9M |
© 2024 Yahoo. All rights reserved.